Task: Answer the multiple-choice question.
Query: Which drug exhibits a 0.373% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCC(C)NC(=O)C(Cc1ccccc1)n1cccc1
b Clc1ccc(-c2csc(N/N=C/c3cccnc3)n2)c(Cl)c1
c CCOC(=O)c1cc(-c2ccccc2)sc1NC(=O)c1cc(OC)c(OC)c(OC)c1
Answer: a. CCC(C)NC(=O)C(Cc1ccccc1)n1cccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)NC(=O)C(Cc1ccccc1)n1cccc1
CCC(C)NC(=O)C(Cc1ccccc1)n1cccc1
N-butan-2-yl-3-phenyl-2-pyrrol-1-ylpropanamide